EZ EM INC
8-K, 1997-10-21
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ELECTRONIC CLEARING HOUSE INC, SC 13D, 1997-10-21
Next: KAISER VENTURES INC, SC 13D/A, 1997-10-21



                                UNITED STATES

                     SECURITIES AND EXCHANGE COMMISSION

                           Washington, D.C. 20549


                                  FORM 8-K


                               CURRENT REPORT


   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



                               October 8, 1997
                      ---------------------------------
                               Date of Report
                      (Date of earliest event reported)



                                E-Z-EM, Inc.
           ------------------------------------------------------
           (Exact name of registrant as specified in its charter)



              Delaware                 1-11479            11-1999504
    ----------------------------     ------------     -------------------
    (State or other jurisdiction     (Commission       (I.R.S. Employer
          of incorporation)          File Number)     Identification No.)



              717 Main Street, Westbury, New York          11590
           ----------------------------------------     ----------
           (Address of principal executive offices)     (Zip Code)



                                (516) 333-8230
                       -------------------------------
                       (Registrant's telephone number,
                            including area code)



                               Not Applicable
        -------------------------------------------------------------
        (Former name or former address, if changed since last report)


                                Page 1 of 3
                           Exhibit Index on Page 2

<PAGE>


Item 5.  Other Events
         ------------

     On October 8, 1997, E-Z-EM, Inc. (the "Company") issued a press release
concerning the resignation of the Company's President, Chief Executive
Officer and Director, Mr. Daniel R. Martin.  A copy of the press release is
attached hereto as exhibit 99.1.


Item 7.  Financial Statements and Exhibits
         ---------------------------------

     (a)  Financial statements of businesses acquired

          Not applicable

     (b)  Pro forma financial information

          Not applicable

     (c)  Exhibits

           No.                      Description                        Page
           --                       -----------                        ----

          99.1          Press Release dated October 8, 1997              3
                        issued by the Company


                                 SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.




                                          E-Z-EM, Inc.
                                         -----------------------------------
                                          (Registrant)




Date   October 20, 1997                   /s/ Dennis J. Curtin
     --------------------                -----------------------------------
                                          Dennis J. Curtin, Vice President-
                                          Chief Financial Officer





                                                           Exhibit 99.1


                                PRESS RELEASE
============================================================================
October 8, 1997
E-Z-EM, INC. PRESS RELEASE


E-Z-EM BOARD ANNOUNCES THE RESIGNATION OF PRESIDENT AND CEO DANIEL R. MARTIN


WESTBURY, NY, OCTOBER 8, 1997  E-Z-EM today announced that Daniel R. Martin,
after consultation with E-Z-EM's board of directors, has resigned his
position as President, Chief Executive Officer and Director in order to
pursue another opportunity.  The Board of Directors has retained Korn Ferry
International, an executive search firm to initiate a search for a new
President/CEO.

Heading the search for a new CEO will be a committee composed of Board Vice
Chairman Paul Echenberg, E-Z-EM Board members David P. Meyers, Donald A.
Meyer and Chairman of the Board Howard S. Stern.  Until a new CEO is hired,
Mr. Stern will assume additional responsibilities for the Company's day-to-
day operations working closely with the board and the executive management
team.

According to Mr. Stern, "Speaking for the entire Board, we are committed to
expanding and diversifying E-Z-EM's contrast media business through
continued licensing, accelerating new product development and line
extensions as well as searching for additional product licensing and
acquisition opportunities."

E-Z-EM is the world's largest manufacturer of contrast agents for
gastrointestinal radiology, and has major divisions engaged in
interventional radiology and diagnostics.  For additional information,
please contact Howard S. Stern at (516) 333-8230.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission